BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37433432)

  • 1. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
    Benson AB; D'Angelica MI; Abrams T; Abbott DE; Ahmed A; Anaya DA; Anders R; Are C; Bachini M; Binder D; Borad M; Bowlus C; Brown D; Burgoyne A; Castellanos J; Chahal P; Cloyd J; Covey AM; Glazer ES; Hawkins WG; Iyer R; Jacob R; Jennings L; Kelley RK; Kim R; Levine M; Palta M; Park JO; Raman S; Reddy S; Ronnekleiv-Kelly S; Sahai V; Singh G; Stein S; Turk A; Vauthey JN; Venook AP; Yopp A; McMillian N; Schonfeld R; Hochstetler C
    J Natl Compr Canc Netw; 2023 Jul; 21(7):694-704. PubMed ID: 37433432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region.
    Yusuf MA; Kapoor VK; Kamel RR; Kazmi A; Uddin N; Masood N; Al-Abdulkareem A;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S36-40. PubMed ID: 20697130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatobiliary cancers, version 2.2014.
    Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
    J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary tract cancer.
    Curley SA
    Cancer Treat Res; 1997; 90():273-307. PubMed ID: 9367089
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical relevance of the new S3 guideline on hepatocellular carcinoma and biliary tract cancer for practitioners].
    Voesch S; Bitzer M; Malek N
    Radiologe; 2022 Mar; 62(3):200-204. PubMed ID: 35147708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
    Vogel A; Bridgewater J; Edeline J; Kelley RK; Klümpen HJ; Malka D; Primrose JN; Rimassa L; Stenzinger A; Valle JW; Ducreux M;
    Ann Oncol; 2023 Feb; 34(2):127-140. PubMed ID: 36372281
    [No Abstract]   [Full Text] [Related]  

  • 7. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.
    Nagino M; Kamiya J; Nishio H; Ebata T; Arai T; Nimura Y
    Ann Surg; 2006 Mar; 243(3):364-72. PubMed ID: 16495702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging.
    Campbell WL; Ferris JV; Holbert BL; Thaete FL; Baron RL
    Radiology; 1998 Apr; 207(1):41-50. PubMed ID: 9530297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database.
    Kim BW; Oh CM; Choi HY; Park JW; Cho H; Ki M
    Gut Liver; 2019 Jan; 13(1):104-113. PubMed ID: 29938462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
    Benson AB; D'Angelica MI; Abbott DE; Abrams TA; Alberts SR; Saenz DA; Are C; Brown DB; Chang DT; Covey AM; Hawkins W; Iyer R; Jacob R; Karachristos A; Kelley RK; Kim R; Palta M; Park JO; Sahai V; Schefter T; Schmidt C; Sicklick JK; Singh G; Sohal D; Stein S; Tian GG; Vauthey JN; Venook AP; Zhu AX; Hoffmann KG; Darlow S
    J Natl Compr Canc Netw; 2017 May; 15(5):563-573. PubMed ID: 28476736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of imaging in the diagnosis and staging of hepatobiliary malignancies.
    Miller G; Schwartz LH; D'Angelica M
    Surg Oncol Clin N Am; 2007 Apr; 16(2):343-68. PubMed ID: 17560517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.
    Wheless M; Agarwal R; Goff L; Lockney N; Padmanabhan C; Heumann T
    Curr Treat Options Oncol; 2024 Jan; 25(1):127-160. PubMed ID: 38177560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 46-Year-Old Asian Woman With Liver Mass.
    Morris GJ; Covey AM; D'Angelica M; Chang DT; Yen Y; Kelley RK; Greenberg H; Tsioulias G
    Semin Oncol; 2015 Oct; 42(5):e67-76. PubMed ID: 26433558
    [No Abstract]   [Full Text] [Related]  

  • 14. How I treat biliary tract cancer.
    Lamarca A; Edeline J; Goyal L
    ESMO Open; 2022 Feb; 7(1):100378. PubMed ID: 35032765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare histotypes of epithelial biliary tract tumors: A literature review.
    Sapuppo E; Brunetti O; Tessitore D; Brandi G; Di Giovanni N; Fadda G; Luchini C; Martini M; Quaresmini D; Russo A; Santarpia M; Scarpa A; Scartozzi M; Tuccari G; Franchina T; Silvestris N
    Crit Rev Oncol Hematol; 2023 Jan; 181():103892. PubMed ID: 36481306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers.
    Itoi T; Shinohara Y; Takeda K; Nakamura K; Shimizu M; Ohyashiki K; Hisatomi H; Nakano H; Moriyasu F
    Int J Mol Med; 2001 Mar; 7(3):281-7. PubMed ID: 11179508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancies of the biliary tree.
    Pitt HA; Dooley WC; Yeo CJ; Cameron JL
    Curr Probl Surg; 1995 Jan; 32(1):1-90. PubMed ID: 7528652
    [No Abstract]   [Full Text] [Related]  

  • 18. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Benson AB; D'Angelica MI; Abbott DE; Anaya DA; Anders R; Are C; Bachini M; Borad M; Brown D; Burgoyne A; Chahal P; Chang DT; Cloyd J; Covey AM; Glazer ES; Goyal L; Hawkins WG; Iyer R; Jacob R; Kelley RK; Kim R; Levine M; Palta M; Park JO; Raman S; Reddy S; Sahai V; Schefter T; Singh G; Stein S; Vauthey JN; Venook AP; Yopp A; McMillian NR; Hochstetler C; Darlow SD
    J Natl Compr Canc Netw; 2021 May; 19(5):541-565. PubMed ID: 34030131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.